Browsing byAuthorSayed, AA
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
| 2021-06 | Demethyleneberberine: A possible treatment for Huntington’s disease | Gupta, S; Khan, A; Vishwas, S; Gulati, M; Gurjeet Singh, T; Dua, K; Kumar Singh, S; Najda, A; Sayed, AA; Almeer, R; Abdel-Daim, MM |
| 2023-11 | Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases | Singh, N; Vishwas, S; Kaur, A; Kaur, H; Kakoty, V; Khursheed, R; Chaitanya, MVNL; Babu, MR; Awasthi, A; corrie, L; Harish, V; Yanadaiah, P; Gupta, S; Sayed, AA; El-Sayed, A; Ali, I; Kensara, OA; Ghaboura, N; Gupta, G; Dou, AM; Algahtani, M; El-kott, AF; Dua, K; Singh, SK; Abdel-Daim, MM |
| 2008-11-01 | Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages | Donnelly, S; Stack, CM; O'Neill, SM; Sayed, AA; Williams, DL; Dalton, JP |
| - | Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route | Smriti,; Singla, M; Gupta, S; Porwal, O; Nasser Binjawhar, D; Sayed, AA; Mittal, P; El-Demerdash, FM; Algahtani, M; Singh, SK; Dua, K; Gupta, G; Bawa, P; Altyar, AE; Abdel-Daim, MM |
